Mutual Pharmaceutical recalls

Mutual Pharmaceutical has 14 recalls on record with the FDA and USDA, the earliest in 2014 and the latest reported on 27 Jan 2016.

Total recalls14since 2014
Last 12 months0reported
Class I00% of total
Ongoing0latest 27 Jan 2016

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 5 36%Class III 9 64%

Why mutual pharmaceutical is recalled

By year

All mutual pharmaceutical recalls, newest first

14 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IISulfamethoxazole and Trimethoprim Tablets recalledMutual PharmaceuticalOtherMS
DrugCLASS IIIImipramine HCl Tablets, USP, 10 mg recalledMutual PharmaceuticalOtherNationwide
DrugCLASS IIIImipramine HCl Tablets, USP, 25 mg recalledMutual PharmaceuticalOtherNationwide
DrugCLASS IIIImipramine HCl Tablets, USP, 50 mg recalledMutual PharmaceuticalOtherNationwide
DrugCLASS IIIFelodipine Extended-Release Tablets, 5 mg recalledMutual PharmaceuticalOtherNationwide
DrugCLASS IIIFelodipine Extended-Release Tablets, 10 mg recalledMutual PharmaceuticalOtherNationwide
DrugCLASS IIIFelodipine Extended-Release Tablets, 2.5 mg recalledMutual PharmaceuticalOtherNationwide
DrugCLASS IIClonidine Hydrochloride Tablets, USP, 0.2 mg recalledMutual PharmaceuticalManufacturing (CGMP) DeviationsPA
DrugCLASS IIClonidine Hydrochloride Tablets, USP, 0.1 mg recalledMutual PharmaceuticalManufacturing (CGMP) DeviationsPA
DrugCLASS IIClonidine Hydrochloride Tablets, USP, 0.3 mg HDPE recalledMutual PharmaceuticalManufacturing (CGMP) DeviationsPA
DrugCLASS IIErgoloid Mesylates recalled by Mutual Pharmaceutical CompanyMutual PharmaceuticalPotency & AssayNationwide
DrugCLASS IIIFenofibric Acid, immediate release tablet, 35 mg recalledMutual PharmaceuticalOtherNationwide
DrugCLASS IIIFibricor (fenofibric acid) Tablets, 105 mg, a) bottle recalledMutual PharmaceuticalOtherNationwide
DrugCLASS IIIFenofibric Acid, immediate release tablet, 105 mg, a) bottle recalledMutual PharmaceuticalOtherNationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.